Understanding the knowledge structure and the value creation process of the metaverse. [PDF]
Ramírez-Herrero V +2 more
europepmc +1 more source
Correction: Value in psoriasis (IRIS) trial: implementing value-based healthcare in psoriasis management - a 1-year prospective clinical study to evaluate feasibility and value creation. [PDF]
europepmc +1 more source
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant +11 more
wiley +1 more source
Comparison of acid and hydrothermal pretreatments of date waste for value creation. [PDF]
Oladzad S +5 more
europepmc +1 more source
Value-creation in the health data domain: a typology of what health data help us do. [PDF]
Fiske A +3 more
europepmc +1 more source
CEACAM1 participation in breast cancer progression
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin +3 more
wiley +1 more source
Encourage or Reject Employee Involvement: Value Creation in Human Resource Management in the AI Era-An Evolutionary Game Analysis of Enterprises and Employees. [PDF]
Yang X, Yan S.
europepmc +1 more source
A value creation model from science-society interconnections: Archetypal analysis combining publications, survey and altmetric data. [PDF]
Ramos-Vielba I +2 more
europepmc +1 more source
Spatial biology in cancer epigenetics
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley +1 more source

